바이오헤이븐 (BHVN)

전일 마감가:

$38.97

열려 있는:

$39.3

하루 거래량:

183.05K

시가총액:

$3.44B

수익:

-

순이익/손실:

$-408.17M

주가수익비율:

-5.249

EPS:

-7.47

순현금흐름:

$-334.77M

1주 성능:

+2.36%

1개월 성능:

-28.26%

6개월 성능:

+46.18%

1년 성능:

+199.96%

1일 변동 폭

$38.54

$39.54

52주 변동 폭

$12.96

$62.21

바이오헤이븐 Stock (BHVN) Company Profile

명칭

Biohaven Ltd

부문

Healthcare (1203)

산업

Biotechnology (688)

전화

203-404-0410

주소

234 Church Street, New Haven, CT

직원

57

트위터

@biohavenpharma

다음 수익 날짜

2022-11-07T13:30:00.000Z

최신 SEC 제출 서류

BHVN's Discussions on Twitter

바이오헤이븐 Stock (BHVN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-02-16	개시	RBC Capital Mkts	Outperform
2024-02-06	개시	UBS	Buy
2023-12-22	개시	H.C. Wainwright	Buy
2023-12-08	개시	Robert W. Baird	Outperform
2023-01-24	개시	SVB Securities	Outperform
2023-01-04	개시	JP Morgan	Overweight
2022-12-02	개시	BTIG Research	Buy
2022-10-26	업그레이드	Cantor Fitzgerald	Neutral → Overweight
2022-10-12	개시	Piper Sandler	Overweight
2022-08-19	다운그레이드	Piper Sandler	Overweight → Neutral
2022-08-08	다운그레이드	Wedbush	Outperform → Neutral
2022-05-11	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2021-10-19	재개	Morgan Stanley	Equal-Weight
2021-08-10	다운그레이드	UBS	Buy → Neutral
2021-08-03	재확인	Canaccord Genuity	Buy
2021-03-11	개시	UBS	Buy
2020-12-15	개시	H.C. Wainwright	Buy
2020-04-17	개시	Cowen	Outperform
2020-02-10	다운그레이드	Oppenheimer	Outperform → Perform
2020-02-06	개시	Mizuho	Buy
2019-11-22	개시	Wedbush	Outperform
2019-06-25	재확인	Canaccord Genuity	Buy
2019-05-06	개시	Goldman	Buy
2019-04-09	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2019-03-04	재확인	Needham	Buy
2018-07-03	재확인	Needham	Buy
2018-07-02	재확인	Needham	Buy
2018-04-05	다운그레이드	Barclays	Overweight → Equal Weight
2018-02-22	재확인	Canaccord Genuity	Buy
2017-12-15	개시	Canaccord Genuity	Buy
2017-10-03	재확인	Needham	Buy

모두보기

바이오헤이븐 주식(BHVN)의 최신 뉴스

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space

Benzinga

Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky

MarketWatch

Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky

MarketWatch

FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga

Arcellx (ACLX) Up 5% on Partnership Expansion With Gilead

Zacks Investment Research

바이오헤이븐 (BHVN) 재무 분석

바이오헤이븐 (BHVN) 순이익 2024

바이오헤이븐 (BHVN) 현금흐름 2024

바이오헤이븐 (BHVN) 주당 순이익 2024